Evidence map›Paper›PMID 38640233›Full record

ArticleScience advances2024

The immune-evasive proline-283 substitution in influenza nucleoprotein increases aggregation propensity without altering the native structure.

Jimin Yoon, Yu Meng Zhang, Cheenou Her, Robert A Grant, Anna I Ponomarenko, Bryce E Ackermann, Tiffani Hui, Yu-Shan Lin, Galia T Debelouchina, Matthew D Shoulders

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Identification of an on-pathway intermediate illuminates the kinetic competition between protein folding and misfolding.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jimin YoonDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0002-7010-082X
Yu Meng ZhangDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0009-0007-0039-7625
Cheenou HerDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA.
Robert A GrantDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Anna I PonomarenkoDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.
Bryce E AckermannDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA.
Tiffani HuiDepartment of Chemistry, Tufts University, Medford, MA, USA.
Yu-Shan LinDepartment of Chemistry, Tufts University, Medford, MA, USA.ORCID 0000-0001-6460-2877
Galia T DebelouchinaDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0001-6775-9415
Matthew D ShouldersDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0002-6511-3431
Massachusetts Institute of Technology · USUniversity of California San Diego · USTufts University · USBroad Institute · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jacqueline A. Lees · 1985 to 2026
$93.9M
User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI STEVEN E EALICK · 2018 to 2026
$34.2M
TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI NILES, JACQUIN C · 1985 to 2020
$25.6M
Defining the Interplay Between Viral Adaptation and Host ProteostasisR01AI168166 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Matthew Donald Shoulders · 2022 to 2026
$2.9M
Structural biology of chromatin in vitro and in cellsR35GM138382 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Galia Debelouchina · 2020 to 2026
$2.8M
Leveraging Next-Generation Directed Evolution Platforms and Chemical Control of Proteostasis to Deliver Robust Biotechnologies and Illuminate Roles of Chaperone Networks in Protein EvolutionR35GM136354 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHOULDERS, MATTHEW DONALD · 2020 to 2024
$2.1M
Pixel Array Detector for Macromolecular CrystallographyS10OD021527 · OD · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2016 to 2016
$2.0M
NCI NIH HHS P30 CA014051NIAID NIH HHS R01 AI168166NIEHS NIH HHS P30 ES002109NIGMS NIH HHS P30 GM124165NIGMS NIH HHS R35 GM136354NIGMS NIH HHS R35 GM138382NIH HHS S10 OD021527
6 · The paper itself

Abstract

Nucleoprotein (NP) is a key structural protein of influenza ribonucleoprotein complexes and is central to viral RNA packing and trafficking. NP also determines the sensitivity of influenza to myxovirus resistance protein 1 (MxA), an innate immunity factor that restricts influenza replication. A few critical MxA-resistant mutations have been identified in NP, including the highly conserved proline-283 substitution. This essential proline-283 substitution impairs influenza growth, a fitness defect that becomes particularly prominent at febrile temperature (39°C) when host chaperones are depleted. Here, we biophysically characterize proline-283 NP and serine-283 NP to test whether the fitness defect is caused by the proline-283 substitution introducing folding defects. We show that the proline-283 substitution changes the folding pathway of NP, making NP more aggregation prone during folding, but does not alter the native structure of the protein. These findings suggest that influenza has evolved to hijack host chaperones to promote the folding of otherwise biophysically incompetent viral proteins that enable innate immune system escape.

Indexed as

Influenza, HumanHumansMyxovirus Resistance ProteinsNucleocapsid ProteinsRNA-Binding ProteinsViral Core ProteinsMyxovirus Resistance ProteinsNucleocapsid ProteinsRNA-Binding ProteinsViral Core Proteins

Identifiers

PMID38640233
PMCPMC11029814
OpenAlexW4394963637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.